This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elliott, M. B.
Right arrow Articles by Hancock, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elliott, M. B.
Right arrow Articles by Hancock, G. E.

 Previous Article  |  Next Article 

Journal of Virology, June 2004, p. 5773-5783, Vol. 78, No. 11
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.11.5773-5783.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Recombinant Respiratory Syncytial Viruses Lacking the C-Terminal Third of the Attachment (G) Protein Are Immunogenic and Attenuated In Vivo and In Vitro

Matthew B. Elliott,1 Karin S. Pryharski,1 Qingzhong Yu,2,{dagger} Christopher L. Parks,2 Todd S. Laughlin,1,{ddagger} C. Kanta Gupta,2 Robert A. Lerch,2 Valerie B. Randolph,2 Natisha A. LaPierre,1 Kristen M. Heers Dack,1,§ and Gerald E. Hancock1*

Departments of Immunology,1 Viral Vaccine Research, Wyeth Vaccines Research, Pearl River, New York 109652

Received 14 November 2003/ Accepted 29 January 2004

The design of attenuated vaccines for respiratory syncytial virus (RSV) historically focused on viruses made sensitive to physiologic temperature through point mutations in the genome. These prototype vaccines were not suitable for human infants primarily because of insufficient attenuation, genetic instability, and reversion to a less-attenuated phenotype. We therefore sought to construct novel attenuated viruses with less potential for reversion through genetic alteration of the attachment G protein. Complete deletion of G protein was previously shown to result in RSV strains overly attenuated for replication in mice. Using reverse genetics, recombinant RSV (rRSV) strains were engineered with truncations at amino acid 118, 174, 193, or 213 and respectively designated rA2cp{Delta}G118, rA2cp{Delta}G174, rA2cp{Delta}G193, and rA2cp{Delta}G213. All rA2cp{Delta}G strains were attenuated for growth in vitro and in the respiratory tracts of BALB/c mice but not restricted for growth at 37°C. The mutations did not significantly affect nascent genome synthesis in human lung epithelial (A549) cells, but infectious rA2cp{Delta}G virus shed into the culture medium was dramatically diminished. Hence, the data suggested that a site within the C-terminal 85 amino acids of G protein is important for efficient genome packaging or budding of RSV from the infected cell. Vaccination with the rA2cp{Delta}G strains also generated efficacious immune responses in mice that were similar to those elicited by the temperature-sensitive cpts248/404 strain previously tested in human infants. Collectively, the data indicate that the rA2cp{Delta}G strains are immunogenic, not likely to revert to the less-attenuated phenotype, and thus candidates for further development as vaccines against RSV.

* Corresponding author. Mailing address: Wyeth Vaccines Research, 401 N. Middletown Rd., Pearl River, NY 10965. Phone: (845) 602-8358. Fax: (845) 602-4941. E-mail: hancocg{at}wyeth.com.

{dagger} Present address: USDA, Southeast Poultry Research Laboratory, Athens, GA 30605.

{ddagger} Present address: Ortho-Clinical Diagnostics, Rochester, NY 14626.

§ Present address: Division of Pediatric Hematology/Oncology, Golisano's Children's Hospital at Strong, Rochester, NY 14642.

Journal of Virology, June 2004, p. 5773-5783, Vol. 78, No. 11
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.11.5773-5783.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Elliott, M. B., Pryharski, K. S., Yu, Q., Boutilier, L. A., Campeol, N., Melville, K., Laughlin, T. S., Gupta, C. K., Lerch, R. A., Randolph, V. B., LaPierre, N. A., Dack, K. M. H., Hancock, G. E. (2004). Characterization of Recombinant Respiratory Syncytial Viruses with the Region Responsible for Type 2 T-Cell Responses and Pulmonary Eosinophilia Deleted from the Attachment (G) Protein. J. Virol. 78: 8446-8454 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»